Metal Neurovascular Stent

Metal Neurovascular Stent Market Outlook

The global metal neurovascular stent market is projected to reach approximately USD 2.5 billion by 2035, growing at a robust CAGR of around 6.5% during the forecast period from 2025 to 2035. This growth is primarily driven by the increasing prevalence of neurovascular diseases, such as aneurysms and strokes, alongside advancements in stent technology that enhance the efficacy and safety of interventions. Additionally, the rising geriatric population, who are at higher risk for these conditions, combined with an increase in healthcare expenditure, is expected to significantly contribute to market expansion. The growing awareness regarding minimally invasive procedures, coupled with the burgeoning number of neurovascular surgeries performed globally, further supports the market's upward trajectory. As healthcare systems continue to evolve with innovative technologies and improved clinical techniques, the metal neurovascular stent market is set for substantial growth in the coming years.

Growth Factor of the Market

One of the primary growth factors for the metal neurovascular stent market is the increasing incidence of neurovascular disorders, which necessitate effective interventional treatment options. As populations age, the prevalence of conditions such as aneurysms and strokes is on the rise, leading to greater demand for neurovascular stenting procedures. Additionally, advancements in stent design and biocompatibility are enhancing patient outcomes and driving the adoption of metal stents in clinical practice. Furthermore, the increasing awareness and acceptance of minimally invasive surgical techniques among healthcare professionals and patients alike plays a pivotal role in propelling market growth. The healthcare sector's ongoing investment in research and innovation, particularly in the development of novel stent materials and designs, is expected to contribute significantly to the expansion of the market. Moreover, favorable reimbursement policies for minimally invasive procedures are incentivizing healthcare providers to adopt these technologies, further driving demand.

Key Highlights of the Market

• The market is anticipated to witness a CAGR of 6.5% from 2025 to 2035.
• Technological advancements in stent manufacturing are improving efficacy and patient outcomes.
• Minimally invasive surgical techniques are gaining popularity among practitioners and patients.
• Increasing awareness and clinical evidence supporting the use of neurovascular stents are driving adoption.
• The geriatric population's growing prevalence of neurovascular diseases is creating significant market opportunities.

By Product Type

Self-Expanding Stents:

Self-expanding stents represent a significant segment of the metal neurovascular stent market, favored for their ability to conform to the anatomy of blood vessels once deployed. These stents are designed to expand on their own upon release from the delivery system, providing a reliable fit in a variety of vascular structures. Their nuanced design not only enhances stability but also minimizes the risk of vessel trauma, which is crucial in neurovascular applications. Self-expanding stents are particularly effective in treating conditions like intracranial aneurysms and stenosis, where an adaptable stent can better accommodate the unique characteristics of the affected vessel. As procedural techniques advance and improved imaging modalities become available, the adoption of self-expanding stents in clinical practice continues to grow, making them a cornerstone of modern neurovascular interventions.

Balloon-Expandable Stents:

Balloon-expandable stents are another critical segment in the metal neurovascular stent market, particularly useful in scenarios where precise diameter adjustments are necessary. These stents are deployed through a balloon catheter, which is inflated to expand the stent against the vessel wall, providing a high level of control over the stent placement and diameter. This feature is particularly beneficial in treating acute ischemic strokes and other conditions where immediate blood flow restoration is critical. The balloon-expandable stents are typically made of rigid materials that enhance durability and provide significant structural support to the vessel. As clinical outcomes continue to improve with the use of these stents, they are becoming increasingly integral in treating various neurovascular diseases, thereby contributing to their growing market share.

Stent-Assisted Coiling:

Stent-assisted coiling is an innovative technique that combines the use of stents and coils to treat intracranial aneurysms effectively. This approach involves placing a stent across the neck of the aneurysm to provide a scaffold for the coiled filling of the aneurysm sac. This dual technique enhances the stability of the coils, reducing the likelihood of coil migration and promoting better flow diversion. As the understanding of aneurysm biology grows, stent-assisted coiling is gaining traction as a preferred method for complex aneurysm cases. This technique's ability to achieve favorable long-term outcomes while minimizing complications drives its adoption and strengthens its position in the metal neurovascular stent market, making it a vital option for interventional neuroradiologists.

Flow Diverters:

Flow diverters represent an advanced category of neurovascular stents designed to treat wide-necked aneurysms. Unlike traditional stents, flow diverters create a barrier to blood flow, diverting it away from the aneurysm sac and promoting thrombosis within the aneurysm, which reduces the risk of rupture. These devices are characterized by their high radial strength and flexibility, allowing them to navigate the complex anatomy of cerebral vessels effectively. The increasing prevalence of challenging aneurysm types and the need for safer treatment options drive the demand for flow diverters in the market. As clinical evidence supporting their efficacy continues to mount, flow diverters are anticipated to play an increasingly prominent role in the future of neurovascular interventions.

Stent-Retriever Devices:

Stent-retriever devices are crucial in the acute treatment of ischemic strokes, as they enable the mechanical removal of thrombi obstructing blood flow in cerebral arteries. These devices function by deploying a stent-like structure that captures the clot, facilitating its retrieval via a catheter. The evolution of stent-retriever technology has significantly improved the outcomes for patients experiencing acute ischemic strokes, making timely intervention more effective. The increasing incidence of stroke, coupled with advancements in stent-retriever designs offering higher efficiency, is propelling the growth of this segment within the metal neurovascular stent market. As stroke care continues to evolve, stent-retrievers will remain at the forefront, emphasizing the importance of rapid treatment to enhance patient survival and recovery rates.

By Application

Intracranial Aneurysm:

Intracranial aneurysms are a leading application driving the demand for metal neurovascular stents. These vascular abnormalities pose significant risks, including rupture, which can lead to life-threatening complications. The use of metal stents in the treatment of aneurysms facilitates effective management by providing structural support and promoting blood flow changes necessary for healing. As awareness of the risks associated with untreated aneurysms grows, more patients are seeking intervention, thereby increasing the demand for neurovascular stents. The ability of stents to enhance the long-term outcomes of aneurysm treatments significantly contributes to their market traction in this segment.

Intracranial Stenosis:

Intracranial stenosis refers to the narrowing of blood vessels within the brain, which can lead to ischemic strokes and other serious complications. The application of metal neurovascular stents in treating stenosis has become increasingly prevalent due to their effectiveness in restoring proper blood flow. Stenting procedures for intracranial stenosis have been shown to improve patient outcomes significantly, particularly in high-risk populations. With the rising prevalence of vascular diseases and improved diagnostic techniques allowing for early detection, the market for neurovascular stents for this application is expected to grow robustly in the coming years.

Acute Ischemic Stroke:

The treatment of acute ischemic stroke using metal neurovascular stents is a rapidly evolving area of the market. Stent-retriever devices specifically designed for acute stroke intervention are revolutionizing patient care by enabling the timely removal of blood clots from occluded vessels. Rapid advancements in stent retriever technology have significantly improved the success rates of thrombolytic therapy, thereby reducing morbidity and mortality associated with strokes. The increasing awareness of stroke symptoms and the importance of immediate treatment is driving the growth of this segment within the neurovascular stent market, as healthcare providers strive to optimize patient outcomes.

Cerebral Atherosclerosis:

Cerebral atherosclerosis, characterized by the buildup of plaques in cerebral arteries, leads to narrowed vessels and reduced blood flow, resulting in serious health risks. The application of metal neurovascular stents in treating this condition helps restore adequate blood flow and reduce the risk of ischemic events. As the understanding of atherosclerosis progresses and its impact on cerebrovascular health is better acknowledged, the demand for stenting procedures to address this condition grows. The focus on preventive care and effective management of atherosclerosis through interventional techniques continues to support the expansion of the metal neurovascular stent market.

Others:

The "Others" segment encompasses various applications of metal neurovascular stents in less common but clinically significant conditions. These include instances such as vascular malformations, arteriovenous fistulas, and other unique vascular challenges requiring interventional treatment. Although these applications may not dominate the market, they contribute to the overall demand for neurovascular stents. As medical technology advances and more applications are identified, the potential for growth in this segment is significant, particularly with the increasing emphasis on personalized medicine and tailored intervention strategies.

By Distribution Channel

Hospitals:

Hospitals are the primary distribution channel for metal neurovascular stents, serving as the main setting for neurovascular procedures. With advanced facilities and specialized healthcare teams, hospitals play a crucial role in the delivery of care for patients requiring stenting interventions. The integration of neurointerventional radiology into hospital systems has expanded the use of metal stents, offering patients timely access to life-saving treatments. As hospitals continue to adopt cutting-edge technologies and improve their services, the demand for neurovascular stents will remain robust within this channel.

Specialty Clinics:

Specialty clinics, focusing on neurovascular treatments, are becoming increasingly prominent as distribution channels for metal neurovascular stents. These clinics often provide a more personalized patient experience, with specialized practitioners dedicated to treating specific conditions. The growth of specialty clinics is facilitated by advancements in telemedicine and outpatient care, allowing for a wider reach to patients needing neurovascular interventions. With the ability to offer tailored treatment plans and increased convenience, specialty clinics are carving out a larger share of the market for neurovascular stents.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are reshaping the landscape of neurovascular stenting by providing cost-effective, high-quality care in an outpatient setting. These centers are equipped to perform various interventional procedures, including stenting, with reduced wait times and lower costs compared to traditional hospital settings. The shift towards outpatient care is driven by patient preferences for convenience and the economic benefits associated with ASCs. As more patients opt for outpatient procedures, the role of ASCs in the metal neurovascular stent market is expected to expand, promoting further innovation and efficiency in treatment delivery.

Online Sales:

Online sales channels for metal neurovascular stents are emerging as a supplementary distribution method, particularly for healthcare providers looking to streamline their procurement processes. The digital transformation of the healthcare industry is enabling manufacturers and distributors to reach a broader audience, providing easier access to various stent products. As telehealth and remote monitoring continue to gain traction, the online distribution of neurovascular products is likely to grow, facilitating faster and more efficient purchasing decisions for hospitals and clinics alike. This trend is expected to enhance market accessibility and further contribute to the overall growth of the metal neurovascular stent market.

By Material Type

Nitinol:

Nitinol, a nickel-titanium alloy, has emerged as a preferred material for metal neurovascular stents due to its unique properties, including super-elasticity and shape memory. These characteristics enable nitinol stents to withstand significant deformation during delivery while returning to their intended shape upon deployment. This flexibility is crucial in navigating the complex structures of cerebral vasculature, making nitinol an ideal choice for various neurovascular applications. The biocompatibility and corrosion resistance of nitinol further enhance its appeal, driving its adoption in the metal neurovascular stent market.

Stainless Steel:

Stainless steel is a traditional material used in the manufacture of metal neurovascular stents, known for its strength and durability. While stainless steel stents offer reliable performance, they tend to lack the flexibility and adaptability of newer materials like nitinol. Nonetheless, they remain a staple in the market due to their affordability and proven track record in clinical settings. Stainless steel stents are particularly effective in straightforward cases where the anatomical requirements are less complex, contributing to their continued relevance in the metal neurovascular stent landscape.

Cobalt-Chromium Alloy:

Cobalt-chromium alloys are gaining popularity in the neurovascular stent market due to their excellent mechanical properties, including high strength and corrosion resistance. These alloys allow for the design of thinner stent struts without sacrificing durability, which enhances vessel patency and reduces the overall profile of the stent. The use of cobalt-chromium alloys is particularly beneficial in complex neurovascular anatomies where stent flexibility and support are critical. As advancements in manufacturing technologies continue to evolve, the presence of cobalt-chromium alloys in the market is expected to increase.

Platinum-Chromium Alloy:

Platinum-chromium alloys are an innovative material choice that offers superior visibility under fluoroscopy, allowing for precise stent placement during procedures. The inherent strength of platinum-chromium allows for the creation of ultra-thin stent designs that enhance patient outcomes by minimizing vessel trauma. The growing preference for advanced imaging techniques and the need for better performance in challenging cases propel the demand for platinum-chromium alloy stents in the metal neurovascular stent market. As the technology matures, these stents are likely to see wider adoption in clinical practice.

Others:

The "Others" category encompasses various alternative materials used in specialized neurovascular stents, including polymers and hybrid materials. These innovative compositions aim to enhance biocompatibility, reduce adverse reactions, and improve the overall functionality of stents in challenging vascular environments. Research focused on developing new materials and coatings is driving interest in this segment, as manufacturers seek to address the limitations of traditional metal stents. The exploration of alternative materials holds promise for the future of neurovascular interventions, expanding options for patients and healthcare providers alike.

By Region

North America is anticipated to hold the largest share of the metal neurovascular stent market throughout the forecast period, driven by advanced healthcare infrastructure, a high prevalence of neurovascular diseases, and significant investments in research and development. The region is expected to account for nearly 40% of the global market share, supported by the growing number of interventional procedures performed annually. Advancements in medical technology and increasing awareness among healthcare professionals and patients further bolster this demand. Additionally, the presence of key players and favorable reimbursement policies enhance the market landscape in North America, leading to a projected CAGR of 6% over the next decade.

Europe represents the second-largest market for metal neurovascular stents, accounting for approximately 25% of the global share. The expanding aging population, along with the rising incidence of neurovascular disorders, drives the demand in this region. Countries such as Germany, France, and the UK are at the forefront of adopting innovative medical technologies, which augments the market's growth. Moreover, the emphasis on improving healthcare services and access to advanced treatment options in Eastern Europe is expected to contribute to market growth. The European market is projected to grow at a CAGR of 5.5%, reflecting a steady rise in neurovascular intervention procedures.

Opportunities

The metal neurovascular stent market presents numerous opportunities for growth, particularly in emerging economies where healthcare infrastructure is rapidly advancing. As countries in Asia Pacific and Latin America enhance their healthcare capabilities, the demand for neurovascular interventions is anticipated to increase significantly. The rising prevalence of neurovascular diseases in these regions, coupled with improved access to treatment, is likely to create a burgeoning market for metal neurovascular stents. Additionally, collaborations between manufacturers and local healthcare providers can facilitate market entry and improve distribution channels, enabling better product availability and potentially driving down costs. Investing in education and training for healthcare professionals in emerging markets will also be vital to promote the adoption of neurovascular stenting procedures.

Moreover, ongoing research and development efforts aimed at improving stent materials and designs present further opportunities. Innovations such as bioresorbable stents, which dissolve after fulfilling their purpose, could revolutionize the treatment of neurovascular disorders by reducing long-term complications associated with permanent implants. The development of next-generation stents featuring advanced drug-eluting technologies also holds promise, as these can enhance outcomes and reduce the risk of restenosis. Establishing partnerships with research institutions and investing in clinical trials will be essential for companies seeking to capitalize on these opportunities and drive the future of the metal neurovascular stent market.

Threats

Despite the promising growth trajectory of the metal neurovascular stent market, several threats pose challenges to its expansion. One significant threat is the increasing competition from alternative treatment options, such as conservative management and pharmacological therapies, which may deter patients from choosing interventional procedures. Additionally, the rising prevalence of minimally invasive surgical techniques may lead to a shift in preference away from traditional stenting methods. As healthcare providers explore various treatment modalities, the market for metal neurovascular stents may face pressure from emerging technologies that offer less invasive or more efficient solutions. Continued vigilance in marketing and education about the benefits of stenting will be crucial to mitigating this threat and maintaining market share.

Regulatory challenges also represent a considerable threat to the metal neurovascular stent market. Stricter regulations surrounding the approval and marketing of medical devices necessitate significant investments in clinical trials and compliance efforts. These requirements can delay product launches and increase costs, potentially limiting the ability of smaller companies to compete with established players. Furthermore, fluctuations in reimbursement policies across different regions can create uncertainty in market dynamics, impacting the adoption of neurovascular stents. Companies must remain agile and adaptable to navigate these regulatory landscapes while ensuring product availability and affordability for healthcare providers and patients alike.

Competitor Outlook

• Medtronic
• Boston Scientific
• Abbott Laboratories
• Stryker Corporation
• Terumo Corporation
• Cardinal Health
• Microvention, Inc.
• Penumbra, Inc.
• B.Braun Melsungen AG
• Asahi Intecc Co., Ltd.
• Johnson & Johnson
• Siemens Healthineers
• Cook Medical
• Cerenovus (a subsidiary of Johnson & Johnson)
• Vascular Solutions, Inc.

The competitive landscape of the metal neurovascular stent market is characterized by the presence of several major players, each striving for innovation and market penetration. Companies like Medtronic and Boston Scientific play pivotal roles, leveraging their extensive portfolios of neurovascular devices to cater to diverse patient needs. Medtronic, for instance, has significantly advanced neurovascular treatment options through its Neurovascular division, offering cutting-edge products that focus on improving clinical outcomes while ensuring patient safety. The company's commitment to research and development has led to the introduction of several novel stent designs, enhancing its competitive edge in this growing market.

Abbott Laboratories is another key competitor, known for its comprehensive range of stenting solutions and emphasis on minimally invasive techniques. The company continues to expand its presence in the neurovascular space by investing in innovation and acquiring smaller firms specializing in cutting-edge technologies. Abbott's focus on developing advanced materials and delivery systems positions it favorably to attract both healthcare providers and patients seeking optimal treatment outcomes. Stryker Corporation also maintains a strong foothold in the market, with its robust portfolio of neurovascular products, including stents and associated interventional devices. The company's strategic collaborations with healthcare institutions further enhance its market presence and foster a culture of innovation.

Asahi Intecc Co., Ltd. and Microvention, Inc. are emerging players in the metal neurovascular stent market, concentrating on specialized applications and novel designs. Asahi Intecc, renowned for its advanced guidewires and microcatheters, complements its offerings with innovative stenting solutions, targeting intricate neurovascular conditions. Microvention, a subsidiary of Terumo Corporation, has gained recognition for its focus on developing unique stenting and coiling products, catering specifically to challenging neurovascular cases. The competition among these players is expected to intensify as the market evolves, highlighting the importance of strategic partnerships, technological advancements, and clinical validation to drive growth and maintain market share.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Cook Medical
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Penumbra, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Cardinal Health
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Boston Scientific
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Johnson & Johnson
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Microvention, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Abbott Laboratories
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Stryker Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 B.Braun Melsungen AG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Siemens Healthineers
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Asahi Intecc Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Vascular Solutions, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Cerenovus (a subsidiary of Johnson & Johnson)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Metal Neurovascular Stent Market, By Application
    • 6.1.1 Intracranial Aneurysm
    • 6.1.2 Intracranial Stenosis
    • 6.1.3 Acute Ischemic Stroke
    • 6.1.4 Cerebral Atherosclerosis
    • 6.1.5 Others
  • 6.2 Metal Neurovascular Stent Market, By Product Type
    • 6.2.1 Self-Expanding Stents
    • 6.2.2 Balloon-Expandable Stents
    • 6.2.3 Stent-Assisted Coiling
    • 6.2.4 Flow Diverters
    • 6.2.5 Stent-Retriever Devices
  • 6.3 Metal Neurovascular Stent Market, By Material Type
    • 6.3.1 Nitinol
    • 6.3.2 Stainless Steel
    • 6.3.3 Cobalt-Chromium Alloy
    • 6.3.4 Platinum-Chromium Alloy
    • 6.3.5 Others
  • 6.4 Metal Neurovascular Stent Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Online Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Metal Neurovascular Stent Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Metal Neurovascular Stent market is categorized based on

By Product Type

• Self-Expanding Stents
• Balloon-Expandable Stents
• Stent-Assisted Coiling
• Flow Diverters
• Stent-Retriever Devices

By Application

• Intracranial Aneurysm
• Intracranial Stenosis
• Acute Ischemic Stroke
• Cerebral Atherosclerosis
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Online Sales

By Material Type

• Nitinol
• Stainless Steel
• Cobalt-Chromium Alloy
• Platinum-Chromium Alloy
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Boston Scientific
• Abbott Laboratories
• Stryker Corporation
• Terumo Corporation
• Cardinal Health
• Microvention, Inc.
• Penumbra, Inc.
• B.Braun Melsungen AG
• Asahi Intecc Co., Ltd.
• Johnson & Johnson
• Siemens Healthineers
• Cook Medical
• Cerenovus (a subsidiary of Johnson & Johnson)
• Vascular Solutions, Inc.